Human prothrombin complex (National Drug Group Wuhan Blood)

人凝血酶原复合物（国药集团武汉生物）

Report date: 2025/08/22 20:01:21

Base Information

Drug NameHuman prothrombin complex (National Drug Group Wuhan Blood)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIIProthrombinCoagulation factor IX +[4] 
Therapy Area/IndicationsHemorrhageHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSinopharm Wuhan Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinopharm Wuhan Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhageHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A